Silicone-Free Prefilled Syringe Packages for Sensitive Biologics and Ophthalmic injections

14 December 2020 13:50 - 14:25

  • Injection volumes of 2 mL are becoming more common, but, USP standards limit particle counts to a quantity per injection
  • Impact of Higher concentrations biologics and concern for aggregation in presence of silicone
  • Floaters, inflammation, interocular pressure increases and silicone presence in injections
  • Impact of Aging and changing injection profiles, resulting in slower or stalled autoinjector injections

Russ Hornung, Business Development for Drug Delivery and Packaging, W.L. Gore & Associates